Duchenne Muscular Dystrophy Market in France - Manufacturing and Consumption, Outlook and Forecast 2020-2026
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
This report contains market size and forecasts of Duchenne Muscular Dystrophy in France, including the following market information:
France Duchenne Muscular Dystrophy Market Revenue, 2015-2020, 2021-2026, ($ millions)
France Duchenne Muscular Dystrophy Market Consumption, 2015-2020, 2021-2026, (K Doses)
France Duchenne Muscular Dystrophy Production Capacity, 2015-2020, 2021-2026, (K Doses)
Top Five Competitors in France Duchenne Muscular Dystrophy Market 2019 (%)
The global Duchenne Muscular Dystrophy market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Duchenne Muscular Dystrophy market size in France was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Duchenne Muscular Dystrophy production and consumption in France
Total Market by Segment:
France Duchenne Muscular Dystrophy Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)
France Duchenne Muscular Dystrophy Market Segment Percentages, By Type, 2019 (%)
France Duchenne Muscular Dystrophy Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Duchenne Muscular Dystrophy Market Competitors Revenues in France, by Players 2015-2020 (Estimated), ($ millions)
Total Duchenne Muscular Dystrophy Market Competitors Revenues Share in France, by Players 2019 (%)
Total France Duchenne Muscular Dystrophy Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)
Total France Duchenne Muscular Dystrophy Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Duchenne Muscular Dystrophy in France, including the following market information:
France Duchenne Muscular Dystrophy Market Revenue, 2015-2020, 2021-2026, ($ millions)
France Duchenne Muscular Dystrophy Market Consumption, 2015-2020, 2021-2026, (K Doses)
France Duchenne Muscular Dystrophy Production Capacity, 2015-2020, 2021-2026, (K Doses)
Top Five Competitors in France Duchenne Muscular Dystrophy Market 2019 (%)
The global Duchenne Muscular Dystrophy market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Duchenne Muscular Dystrophy market size in France was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Duchenne Muscular Dystrophy production and consumption in France
Total Market by Segment:
France Duchenne Muscular Dystrophy Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)
France Duchenne Muscular Dystrophy Market Segment Percentages, By Type, 2019 (%)
- Deflazacort
- Prednisone
- Others
France Duchenne Muscular Dystrophy Market Segment Percentages, By Application, 2019 (%)
- Male
- Female
The report also provides analysis of leading market participants including:
Total Duchenne Muscular Dystrophy Market Competitors Revenues in France, by Players 2015-2020 (Estimated), ($ millions)
Total Duchenne Muscular Dystrophy Market Competitors Revenues Share in France, by Players 2019 (%)
Total France Duchenne Muscular Dystrophy Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)
Total France Duchenne Muscular Dystrophy Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- PTC Therapeutics
- Sarepta Therapeutics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Duchenne Muscular Dystrophy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 France Duchenne Muscular Dystrophy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: FRANCE DUCHENNE MUSCULAR DYSTROPHY OVERALL MARKET SIZE
2.1 France Duchenne Muscular Dystrophy Market Size: 2020 VS 2026
2.2 France Duchenne Muscular Dystrophy Revenue, Prospects & Forecasts: 2015-2026
2.3 France Duchenne Muscular Dystrophy Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Duchenne Muscular Dystrophy Players in France (including Foreign and Local Companies)
3.2 Top France Duchenne Muscular Dystrophy Companies Ranked by Revenue
3.3 France Duchenne Muscular Dystrophy Revenue by Companies (including Foreign and Local Companies)
3.4 France Duchenne Muscular Dystrophy Sales by Companies (including Foreign and Local Companies)
3.5 France Duchenne Muscular Dystrophy Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Duchenne Muscular Dystrophy Companies in France, by Revenue in 2019
3.7 France Manufacturers Duchenne Muscular Dystrophy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Players in France
3.8.1 List of France Tier 1 Duchenne Muscular Dystrophy Companies
3.8.2 List of France Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - France Duchenne Muscular Dystrophy Market Size Markets, 2020 & 2026
4.1.2 Deflazacort
4.1.3 Prednisone
4.1.4 Others
4.2 By Type - France Duchenne Muscular Dystrophy Revenue & Forecasts
4.2.1 By Type - France Duchenne Muscular Dystrophy Revenue, 2015-2020
4.2.2 By Type - France Duchenne Muscular Dystrophy Revenue, 2021-2026
4.2.3 By Type - France Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
4.3 By Type - France Duchenne Muscular Dystrophy Sales & Forecasts
4.3.1 By Type - France Duchenne Muscular Dystrophy Sales, 2015-2020
4.3.2 By Type - France Duchenne Muscular Dystrophy Sales, 2021-2026
4.3.3 By Type - France Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
4.4 By Type - France Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - France Duchenne Muscular Dystrophy Market Size, 2020 & 2026
5.1.2 Male
5.1.3 Female
5.2 By Application - France Duchenne Muscular Dystrophy Revenue & Forecasts
5.2.1 By Application - France Duchenne Muscular Dystrophy Revenue, 2015-2020
5.2.2 By Application - France Duchenne Muscular Dystrophy Revenue, 2021-2026
5.2.3 By Application - France Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
5.3 By Application - France Duchenne Muscular Dystrophy Sales & Forecasts
5.3.1 By Application - France Duchenne Muscular Dystrophy Sales, 2015-2020
5.3.2 By Application - France Duchenne Muscular Dystrophy Sales, 2021-2026
5.3.3 By Application - France Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
5.4 By Application - France Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 PTC Therapeutics
6.1.1 PTC Therapeutics Corporate Summary
6.1.2 PTC Therapeutics Business Overview
6.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.1.4 PTC Therapeutics Sales and Revenue in France (2015-2020)
6.1.5 PTC Therapeutics Key News
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Corporate Summary
6.2.2 Sarepta Therapeutics Business Overview
6.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.2.4 Sarepta Therapeutics Sales and Revenue in France (2015-2020)
6.2.5 Sarepta Therapeutics Key News
6.3 Others
6.3.1 Others Corporate Summary
6.3.2 Others Business Overview
6.3.3 Others Duchenne Muscular Dystrophy Major Product Offerings
6.3.4 Others Sales and Revenue in France (2015-2020)
6.3.5 Others Key News
7 DUCHENNE MUSCULAR DYSTROPHY PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Duchenne Muscular Dystrophy Production Capacity and Value in France, Situation Analysis and Prediction, 2015-2026
7.1.1 France Duchenne Muscular Dystrophy Production Capacity, 2015-2026
7.1.2 France Duchenne Muscular Dystrophy Production 2015-2026
7.1.3 France Duchenne Muscular Dystrophy Production Value 2015-2026
7.2 Key Local Duchenne Muscular Dystrophy Manufacturers in France
7.2.1 France Key Local Duchenne Muscular Dystrophy Manufacturers Production Capacity
7.2.2 France Key Local Duchenne Muscular Dystrophy Manufacturers Production
7.2.3 France Key Local Duchenne Muscular Dystrophy Manufacturers Production Value
7.2.4 The Proportion of Duchenne Muscular Dystrophy Production Sold in France and Sold Other Than France by Manufacturers
7.3 Duchenne Muscular Dystrophy Export and Import in France
7.3.1 France Duchenne Muscular Dystrophy Export Market
7.3.2 France Duchenne Muscular Dystrophy Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for France Duchenne Muscular Dystrophy Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON DUCHENNE MUSCULAR DYSTROPHY SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Duchenne Muscular Dystrophy Distributors and Sales Agents in France
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Duchenne Muscular Dystrophy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 France Duchenne Muscular Dystrophy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: FRANCE DUCHENNE MUSCULAR DYSTROPHY OVERALL MARKET SIZE
2.1 France Duchenne Muscular Dystrophy Market Size: 2020 VS 2026
2.2 France Duchenne Muscular Dystrophy Revenue, Prospects & Forecasts: 2015-2026
2.3 France Duchenne Muscular Dystrophy Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Duchenne Muscular Dystrophy Players in France (including Foreign and Local Companies)
3.2 Top France Duchenne Muscular Dystrophy Companies Ranked by Revenue
3.3 France Duchenne Muscular Dystrophy Revenue by Companies (including Foreign and Local Companies)
3.4 France Duchenne Muscular Dystrophy Sales by Companies (including Foreign and Local Companies)
3.5 France Duchenne Muscular Dystrophy Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Duchenne Muscular Dystrophy Companies in France, by Revenue in 2019
3.7 France Manufacturers Duchenne Muscular Dystrophy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Players in France
3.8.1 List of France Tier 1 Duchenne Muscular Dystrophy Companies
3.8.2 List of France Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - France Duchenne Muscular Dystrophy Market Size Markets, 2020 & 2026
4.1.2 Deflazacort
4.1.3 Prednisone
4.1.4 Others
4.2 By Type - France Duchenne Muscular Dystrophy Revenue & Forecasts
4.2.1 By Type - France Duchenne Muscular Dystrophy Revenue, 2015-2020
4.2.2 By Type - France Duchenne Muscular Dystrophy Revenue, 2021-2026
4.2.3 By Type - France Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
4.3 By Type - France Duchenne Muscular Dystrophy Sales & Forecasts
4.3.1 By Type - France Duchenne Muscular Dystrophy Sales, 2015-2020
4.3.2 By Type - France Duchenne Muscular Dystrophy Sales, 2021-2026
4.3.3 By Type - France Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
4.4 By Type - France Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - France Duchenne Muscular Dystrophy Market Size, 2020 & 2026
5.1.2 Male
5.1.3 Female
5.2 By Application - France Duchenne Muscular Dystrophy Revenue & Forecasts
5.2.1 By Application - France Duchenne Muscular Dystrophy Revenue, 2015-2020
5.2.2 By Application - France Duchenne Muscular Dystrophy Revenue, 2021-2026
5.2.3 By Application - France Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
5.3 By Application - France Duchenne Muscular Dystrophy Sales & Forecasts
5.3.1 By Application - France Duchenne Muscular Dystrophy Sales, 2015-2020
5.3.2 By Application - France Duchenne Muscular Dystrophy Sales, 2021-2026
5.3.3 By Application - France Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
5.4 By Application - France Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 PTC Therapeutics
6.1.1 PTC Therapeutics Corporate Summary
6.1.2 PTC Therapeutics Business Overview
6.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.1.4 PTC Therapeutics Sales and Revenue in France (2015-2020)
6.1.5 PTC Therapeutics Key News
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Corporate Summary
6.2.2 Sarepta Therapeutics Business Overview
6.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.2.4 Sarepta Therapeutics Sales and Revenue in France (2015-2020)
6.2.5 Sarepta Therapeutics Key News
6.3 Others
6.3.1 Others Corporate Summary
6.3.2 Others Business Overview
6.3.3 Others Duchenne Muscular Dystrophy Major Product Offerings
6.3.4 Others Sales and Revenue in France (2015-2020)
6.3.5 Others Key News
7 DUCHENNE MUSCULAR DYSTROPHY PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Duchenne Muscular Dystrophy Production Capacity and Value in France, Situation Analysis and Prediction, 2015-2026
7.1.1 France Duchenne Muscular Dystrophy Production Capacity, 2015-2026
7.1.2 France Duchenne Muscular Dystrophy Production 2015-2026
7.1.3 France Duchenne Muscular Dystrophy Production Value 2015-2026
7.2 Key Local Duchenne Muscular Dystrophy Manufacturers in France
7.2.1 France Key Local Duchenne Muscular Dystrophy Manufacturers Production Capacity
7.2.2 France Key Local Duchenne Muscular Dystrophy Manufacturers Production
7.2.3 France Key Local Duchenne Muscular Dystrophy Manufacturers Production Value
7.2.4 The Proportion of Duchenne Muscular Dystrophy Production Sold in France and Sold Other Than France by Manufacturers
7.3 Duchenne Muscular Dystrophy Export and Import in France
7.3.1 France Duchenne Muscular Dystrophy Export Market
7.3.2 France Duchenne Muscular Dystrophy Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for France Duchenne Muscular Dystrophy Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON DUCHENNE MUSCULAR DYSTROPHY SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Duchenne Muscular Dystrophy Distributors and Sales Agents in France
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Duchenne Muscular Dystrophy in France
Table 2. Top Players in France, Ranking by Revenue (2019)
Table 3. France Duchenne Muscular Dystrophy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. France Duchenne Muscular Dystrophy Revenue Share by Companies, 2015-2020
Table 5. France Duchenne Muscular Dystrophy Sales by Companies, (K Doses), 2015-2020
Table 6. France Duchenne Muscular Dystrophy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Duchenne Muscular Dystrophy Price (2015-2020) (USD/Dose)
Table 8. France Manufacturers Duchenne Muscular Dystrophy Product Type
Table 9. List of France Tier 1 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of France Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Duchenne Muscular Dystrophy Revenue in France (US$, Mn), 2015-2020
Table 12. By Type - Duchenne Muscular Dystrophy Revenue in France (US$, Mn), 2021-2026
Table 13. By Type - Duchenne Muscular Dystrophy Sales in France (K Doses), 2015-2020
Table 14. By Type - Duchenne Muscular Dystrophy Sales in France (K Doses), 2021-2026
Table 15. By Application - Duchenne Muscular Dystrophy Revenue in France, (US$, Mn), 2015-2020
Table 16. By Application - Duchenne Muscular Dystrophy Revenue in France, (US$, Mn), 2021-2026
Table 17. By Application - Duchenne Muscular Dystrophy Sales in France, (K Doses), 2015-2020
Table 18. By Application - Duchenne Muscular Dystrophy Sales in France, (K Doses), 2021-2026
Table 19. PTC Therapeutics Corporate Summary
Table 20. PTC Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 21. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 22. Sarepta Therapeutics Corporate Summary
Table 23. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 24. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 25. Others Corporate Summary
Table 26. Others Duchenne Muscular Dystrophy Product Offerings
Table 27. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 28. Duchenne Muscular Dystrophy Production Capacity (K Doses) of Local Manufacturers in France, 2015-2020
Table 29. Duchenne Muscular Dystrophy Production (K Doses) of Local Manufacturers in France, 2015-2020
Table 30. France Duchenne Muscular Dystrophy Production Market Share of Local Manufacturers, 2015-2020
Table 31. Duchenne Muscular Dystrophy Production Value (US$, Mn) of Local Manufacturers in France, 2015-2020
Table 32. France Duchenne Muscular Dystrophy Production Value Market Share of Local Manufacturers, 2015-2020
Table 33. The Percentage of Duchenne Muscular Dystrophy Production Sold in France and Sold Other Than France by Manufacturers
Table 34. The Percentage of Duchenne Muscular Dystrophy Production Sold in France and Sold Other Than France by Manufacturers
Table 35. Dangeguojia Duchenne Muscular Dystrophy Sales (Consumption), Production, Export and Import, 2015-2020
Table 36. Raw Materials and Suppliers
Table 37. Duchenne Muscular Dystrophy Downstream Clients in France
Table 38. Duchenne Muscular Dystrophy Distributors and Sales Agents in France
Table 1. Key Players of Duchenne Muscular Dystrophy in France
Table 2. Top Players in France, Ranking by Revenue (2019)
Table 3. France Duchenne Muscular Dystrophy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. France Duchenne Muscular Dystrophy Revenue Share by Companies, 2015-2020
Table 5. France Duchenne Muscular Dystrophy Sales by Companies, (K Doses), 2015-2020
Table 6. France Duchenne Muscular Dystrophy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Duchenne Muscular Dystrophy Price (2015-2020) (USD/Dose)
Table 8. France Manufacturers Duchenne Muscular Dystrophy Product Type
Table 9. List of France Tier 1 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of France Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Duchenne Muscular Dystrophy Revenue in France (US$, Mn), 2015-2020
Table 12. By Type - Duchenne Muscular Dystrophy Revenue in France (US$, Mn), 2021-2026
Table 13. By Type - Duchenne Muscular Dystrophy Sales in France (K Doses), 2015-2020
Table 14. By Type - Duchenne Muscular Dystrophy Sales in France (K Doses), 2021-2026
Table 15. By Application - Duchenne Muscular Dystrophy Revenue in France, (US$, Mn), 2015-2020
Table 16. By Application - Duchenne Muscular Dystrophy Revenue in France, (US$, Mn), 2021-2026
Table 17. By Application - Duchenne Muscular Dystrophy Sales in France, (K Doses), 2015-2020
Table 18. By Application - Duchenne Muscular Dystrophy Sales in France, (K Doses), 2021-2026
Table 19. PTC Therapeutics Corporate Summary
Table 20. PTC Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 21. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 22. Sarepta Therapeutics Corporate Summary
Table 23. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 24. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 25. Others Corporate Summary
Table 26. Others Duchenne Muscular Dystrophy Product Offerings
Table 27. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 28. Duchenne Muscular Dystrophy Production Capacity (K Doses) of Local Manufacturers in France, 2015-2020
Table 29. Duchenne Muscular Dystrophy Production (K Doses) of Local Manufacturers in France, 2015-2020
Table 30. France Duchenne Muscular Dystrophy Production Market Share of Local Manufacturers, 2015-2020
Table 31. Duchenne Muscular Dystrophy Production Value (US$, Mn) of Local Manufacturers in France, 2015-2020
Table 32. France Duchenne Muscular Dystrophy Production Value Market Share of Local Manufacturers, 2015-2020
Table 33. The Percentage of Duchenne Muscular Dystrophy Production Sold in France and Sold Other Than France by Manufacturers
Table 34. The Percentage of Duchenne Muscular Dystrophy Production Sold in France and Sold Other Than France by Manufacturers
Table 35. Dangeguojia Duchenne Muscular Dystrophy Sales (Consumption), Production, Export and Import, 2015-2020
Table 36. Raw Materials and Suppliers
Table 37. Duchenne Muscular Dystrophy Downstream Clients in France
Table 38. Duchenne Muscular Dystrophy Distributors and Sales Agents in France
LIST OF FIGURES
Figure 1. Duchenne Muscular Dystrophy Segment by Type
Figure 2. Duchenne Muscular Dystrophy Segment by Application
Figure 3. Dangeguojia Duchenne Muscular Dystrophy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Duchenne Muscular Dystrophy Market Size in France, (US$, Mn) & (K Doses): 2020 VS 2026
Figure 6. France Duchenne Muscular Dystrophy Revenue, 2015-2026 (US$, Mn)
Figure 7. Duchenne Muscular Dystrophy Sales in France: 2015-2026 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Revenue in 2019
Figure 9. By Type - France Duchenne Muscular Dystrophy Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - France Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 11. By Type - France Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 12. By Type - France Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 13. By Application - Duchenne Muscular Dystrophy Revenue in France (US$, Mn), 2020 & 2026
Figure 14. By Application - France Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 15. By Application - France Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 16. By Application -France Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 17. France Duchenne Muscular Dystrophy Production Capacity (K Doses), 2015-2026
Figure 18. France Duchenne Muscular Dystrophy Actual Output (K Doses), 2015-2026
Figure 19. France Duchenne Muscular Dystrophy Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of France Duchenne Muscular Dystrophy Export Destination, 2019
Figure 21. The Source of Imports of France Duchenne Muscular Dystrophy, 2019
Figure 22. PEST Analysis for France Duchenne Muscular Dystrophy Market in 2020
Figure 23. Duchenne Muscular Dystrophy Market Opportunities & Trends in France
Figure 24. Duchenne Muscular Dystrophy Market Drivers in France
Figure 25. Duchenne Muscular Dystrophy Market Restraints in France
Figure 26. Duchenne Muscular Dystrophy Industry Value Chain
Figure 1. Duchenne Muscular Dystrophy Segment by Type
Figure 2. Duchenne Muscular Dystrophy Segment by Application
Figure 3. Dangeguojia Duchenne Muscular Dystrophy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Duchenne Muscular Dystrophy Market Size in France, (US$, Mn) & (K Doses): 2020 VS 2026
Figure 6. France Duchenne Muscular Dystrophy Revenue, 2015-2026 (US$, Mn)
Figure 7. Duchenne Muscular Dystrophy Sales in France: 2015-2026 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Revenue in 2019
Figure 9. By Type - France Duchenne Muscular Dystrophy Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - France Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 11. By Type - France Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 12. By Type - France Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 13. By Application - Duchenne Muscular Dystrophy Revenue in France (US$, Mn), 2020 & 2026
Figure 14. By Application - France Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 15. By Application - France Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 16. By Application -France Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 17. France Duchenne Muscular Dystrophy Production Capacity (K Doses), 2015-2026
Figure 18. France Duchenne Muscular Dystrophy Actual Output (K Doses), 2015-2026
Figure 19. France Duchenne Muscular Dystrophy Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of France Duchenne Muscular Dystrophy Export Destination, 2019
Figure 21. The Source of Imports of France Duchenne Muscular Dystrophy, 2019
Figure 22. PEST Analysis for France Duchenne Muscular Dystrophy Market in 2020
Figure 23. Duchenne Muscular Dystrophy Market Opportunities & Trends in France
Figure 24. Duchenne Muscular Dystrophy Market Drivers in France
Figure 25. Duchenne Muscular Dystrophy Market Restraints in France
Figure 26. Duchenne Muscular Dystrophy Industry Value Chain
